Fufang Gancao Pian (复方甘草片)复方甘草片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 国药集团新疆制药有限公司Chinese legal name: 国药集团新疆制药有限公司
主要成分Active Ingredients
- 复方制剂Compound preparation
药物知识说明
复方制剂是一种在国家药监局注册认定的药品。该药品含有复方制剂-691fe176等成分。
该药品关联的活性成分包括：复方制剂Compound preparation。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：国药集团新疆制药有限公司Chinese legal name: 国药集团新疆制药有限公司。
您可以探索含有相同成分的其他药品：复方制剂-691fe176成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 复方甘草片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 复方制剂Compound preparation.
Manufacturers recorded for this product: 国药集团新疆制药有限公司Chinese legal name: 国药集团新疆制药有限公司.
Explore other medicines containing the same ingredient: 复方制剂 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 复方甘草片Recorded Chinese name: 复方甘草片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 复方Recorded Chinese specification
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 国药集团新疆制药有限公司Chinese legal name: 国药集团新疆制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H65020280
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H65020280
Manufacturer
Chinese legal name: 国药集团新疆制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H65020280
生产企业
国药集团新疆制药有限公司(国产)
适应症
本品用于镇咳祛痰。
用法用量
口服或含化。成人一次3-4片，一日3次。
不良反应
本品有轻微的恶心、呕吐反应。
禁忌
1.一般情况下复方甘草片不宜于与下列药物配伍使用。
2.强心甙类 复方甘草片中甘草浸膏能促进机体钾排泄，使机体血钾浓度降低，因而可增强机体对强心甙的敏感性，易诱发强心甙的敏感性。
注意事项
1.本品注意事项为:
2.本品不宜长期服用，如服用3～7天症状未缓解，请即时咨询医师。
3.对本品成份过敏者禁用。
4.孕妇及哺乳期妇女慎用。
5.胃炎及胃溃疡患者慎用。
6.儿童用量请咨询医师或药师。
7.当本品性状发生改变时禁用。
8.如服用过量或发生严重不良反应时应立即就医。
9.儿童必须在成人监护下使用。
10.请将此药品放在儿童不能接触的地方。
贮藏
遮光，密封保存。
规格
复方
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.